does medicaid cover glp 1 in nc fuels US coverage of Novo, Lilly weight-loss drugs The evolving landscape of anti-obesity

doi: 10.1126/science.1083516

Why Muscle Loss Is the Real Challenge for GLP-1 Users GLP-1 medications work by reducing appetite and slowing digestion, which leads to a significant calorie deficit over time

They are game-changers in appetite suppression and blood sugar management

Four Key Focus Areas Focus 1: GLP-1 Franchise (Mounjaro + Zepbound) Sales Surge Mounjaro (diabetes) and Zepbound (obesity) remain the primary revenue engines

Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2025

POLG mutation in a patient with cataracts, early-onset distal muscle weakness and atrophy, ovarian dysgenesis and 3-methylglutaconic aciduria